Future therapies in T-PLL and T-LGL

Accompanying an upcoming talk at the EHA 2021 virtual congress, our newest perspective on novel therapy approaches in mature T-cell leukemias was published in Hemasphere. In “Hijacking the Pathway: Perspectives in the Treatment of Mature T-cell Leukemias“, Linus Wahnschaffe and Marco Herling discuss future approaches for T-PLL and T-LGL that are based on current molecular disease concepts as well as on encouraging preclinical and early clinical data.

Read the perspective:

Hijacking the Pathway: Perspectives in the Treatment of Mature T-cell Leukemias